Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No additions or deletions were provided, so there are no identifiable changes to the page content.
    Difference
    0.0%
    Check dated 2026-07-11T06:43:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record page now shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects an updated version of the page rendering rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-04T03:51:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the Study Details page, representing a backend/content update to the page without altering the study data shown.
    Difference
    0.0%
    Check dated 2026-06-26T20:04:42.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The study record's timestamps were updated, adding June 2026 updates and removing earlier March–April entries, reflecting routine registry maintenance rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-19T17:39:10.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now indicates recruitment has ended and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading is updated and the revision note updated to v3.6.0, replacing the earlier label.
    Difference
    0.1%
    Check dated 2026-06-12T11:41:27.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a newer revision label (v3.5.5) replacing the previous v3.5.4, indicating an updated page version. This is a versioning update rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-06-05T08:43:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.